Conformis Hurt by Slower Recovery of Total Joint Replacement Surgeries

Conformis logo

Conformis reported 3Q20 orthopedic revenue of USD $16.1 million, -6.8% vs. 3Q19. The company remains impacted by the slower recovery of primary arthroplasty surgeries, its sole line of business, compared to revision and trauma. Leadership expects sequential revenue improvement in the fourth quarter, but lower year over year growth rates due...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us